Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
Nur Samsu,1 Setyawati Soeharto,2 Muhaimin Rifai,3 Achmad Rudijanto41Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine; 2Department of Pharmacology, Faculty of Medicine; 3Department of Biology, Faculty of Mathematics and Sciences; 4Department of Internal Me...
Guardado en:
Autores principales: | Samsu N, Soeharto S, Rifai M, Rudijanto A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dfb10b83fb5e44e79a63eaa11fe96430 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Potential Role of Rosmarinic Acid and Sinensetin as α-Amylase Inhibitor: In Silico Study
por: Hazna Noor Meidinna, et al.
Publicado: (2019) -
Rosmarinic Acid Delays Tomato Fruit Ripening by Regulating Ripening-Associated Traits
por: Changan Zhu, et al.
Publicado: (2021) -
Rosmarinic acid ameliorates renal ischemia reperfusion damage in rats
por: Majid Tavafi, et al.
Publicado: (2020) -
The Beneficial Effect of Rosmarinic Acid on Benzophenone-3-Induced Alterations in Human Skin Fibroblasts
por: Anna Galicka, et al.
Publicado: (2021) -
Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches
por: Madureira AR, et al.
Publicado: (2016)